Microorganisms in contemporary biomedicine and biotechnology



Cite item

Full Text

Abstract

Lecture is devoted to the novel trends in microbiology and to the impact of these developments into the food industry, pharmacology and vaccine development. Methodological part describes general approaches for DNA cloning, synthesis and sequencing. It includes current developments in making artificial bacteria and viruses for the industry and medicine. Special attention is addressed to the microbial therapy which includes usage of health beneficial bacteria as probiotics and personal probiotics (autoprobiotics) for treatment of different pathological conditions including cancer.

Full Text

Restricted Access

About the authors

Alexander Suvorov

ФГБНУ "Институт экспериментальной медицины"

Author for correspondence.
Email: Alexander_suvorov1@hotmail.com
ORCID iD: 0000-0003-2312-5589
SPIN-code: 8062-5281
Scopus Author ID: 7101829979
ResearcherId: J-6921-2013

член-корреспондент РАН, профессор, Отдел молекулярной микробиологии

Russian Federation, Pavlova 12

References

  1. Smith DR, Leggat PA (2005). "Pioneering figures in medicine: Albert Bruce Sabin – inventor of the oral polio vaccine". The Kurume Medical Journal. 52 (3): 111–116. doi: 10.2739/kurumemedj.52.111
  2. Smorodincev A.A. The Efficacy of Live Influenza Vaccines. Bull. World Health Organ. 1969;41:585–588
  3. Molecular cloning. A laboratory manual by T Maniatis, E F Fritsch and J Sambrook. Cold Spring Harbor Laboratory, New York. 1982
  4. Bioorganic chemistry, V140, 2023 https://doi.org/10.1016/j.bioorg.2023.106806
  5. Fraser CM, Gocayne JD, White O, Adams MD, Clayton RA, Fleischmann RD, Bult CJ, Kerlavage AR, Sutton G, Kelley JM, Fritchman RD, Weidman JF, Small KV, Sandusky M, Fuhrmann J, Nguyen D, Utterback TR, Saudek DM, Phillips CA, Merrick JM, Tomb JF, Dougherty BA, Bott KF, Hu PC, Lucier TS, Peterson SN, Smith HO, Hutchison CA 3rd, Venter JC. The minimal gene complement of Mycoplasma genitalium. Science. 1995 Oct 20;270(5235):397-403. doi: 10.1126/science.270.5235.397. PMID: 7569993. (http://dx.doi.org/10.1126/science.aad6253)
  6. Bazan J, Całkosiński I, Gamian A. Phage display--a powerful technique for immunotherapy: 1. Introduction and potential of therapeutic applications. Hum Vaccin Immunother. 2012 Dec 1;8(12):1817-28. doi: 10.4161/hv.21703. Epub 2012 Aug 21. PMID: 22906939; PMCID: PMC3656071
  7. Frackman, S.G.; Franciskovich, P.P.; Jolly, J.F.; Luhm, R.A.; Riedl, W.A In vitro phage lambda DNA packaging system
  8. A commentary on the development of engineered phage as therapeutics Drug Discovery Today, Volume 26, Issue 9, 2021, pp. 2095-2098 Anne M.L. Barnard, Heather I.M. Fairhead
  9. https://doi.org/10.1016/j.chembiol.2022.06.003
  10. http://urn.kb.se/resolve?urn=urn:nbn:se:su:diva-214156
  11. Tamang JP, Watanabe K, Holzapfel WH. Review: Diversity of Microorganisms in Global Fermented Foods and Beverages. Front Microbiol. 2016 Mar 24;7:377. doi: 10.3389/fmicb.2016.00377. PMID: 27047484; PMCID: PMC4805592
  12. Nielsen J, Tillegreen CB, Petranovic D. Innovation trends in industrial biotechnology. Trends Biotechnol. 2022 Oct;40(10):1160-1172. doi: 10.1016/j.tibtech.2022.03.007. Epub 2022 Apr 19. PMID: 35459568)
  13. McCoy M. Myriant starts up succinic acid plant. Chem. Eng. News. 2013; 91: 25
  14. Green M, Arora K, Prakash S. Microbial Medicine: Prebiotic and Probiotic Functional Foods to Target Obesity and Metabolic Syndrome. Int J Mol Sci. 2020 Apr 21;21(8):2890. d
  15. Socała K, Doboszewska U, Szopa A, Serefko A, Włodarczyk M, Zielińska A, Poleszak E, Fichna J, Wlaź P. The role of microbiota-gut-brain axis in neuropsychiatric and neurological disorders. Pharmacol Res. 2021 Oct;172:105840. doi: 10.1016/j.phrs.2021.105840. Epub 2021 Aug 24. PMID: 34450312. oi: 10.3390/ijms21082890. PMID: 32326175; PMCID: PMC7215979..
  16. Yalcin G, Demirbas F, Bacalan F, Toy EB. Evaluation of treatment in acute gastroenteritis: A comparative study. J Pak Med Assoc. 2022 Oct;72(10):2019-2024. doi: 10.47391/JPMA.4438. PMID: 36660970
  17. Jeżewska-Frąckowiak J, Seroczyńska K, Banaszczyk J, Jedrzejczak G, Żylicz-Stachula A, Skowron PM. The promises and risks of probiotic Bacillus species. Acta Biochim Pol. 2018 Dec 6;65(4):509-519. doi: 10.18388/abp.2018_2652. PMID: 30521647
  18. Li HB, Xu ML, Xu XD, Tang YY, Jiang HL, Li L, Xia WJ, Cui N, Bai J, Dai ZM, Han B, Li Y, Peng B, Dong YY, Aryal S, Manandhar I, Eladawi MA, Shukla R, Kang YM, Joe B, Yang T. Faecalibacterium prausnitzii Attenuates CKD via Butyrate-Renal GPR43 Axis. Circ Res. 2022 Oct 14;131(9):e120-e134. doi: 10.1161/CIRCRESAHA.122.320184. Epub 2022 Sep 27. PMID: 36164984; PMCID: PMC9588706
  19. Zhang T, Li Q, Cheng L, Buch H, Zhang F. Akkermansia muciniphila is a promising probiotic. Microb Biotechnol. 2019 Nov;12(6):1109-1125. doi: 10.1111/1751-7915.13410. Epub 2019 Apr 21. PMID: 31006995; PMCID: PMC6801136.
  20. Zhang W, Zhou Q, Liu H, Xu J, Huang R, Shen B, Guo Y, Ai X, Xu J, Zhao X, Liu Y, Wang Y, Zhi F. Bacteroides fragilis strain ZY-312 facilitates colonic mucosa regeneration in colitis via motivating STAT3 signaling pathway induced by IL-22 from ILC3 secretion. Front Immunol. 2023 Apr 11;14:1156762. doi: 10.3389/fimmu.2023.1156762. PMID: 37114045; PMCID: PMC10126674
  21. Abdurasulova IN, Matsulevich AV, Tarasova EA, Kudryavtsev IV, Serebrjakova MK, Ermolenko EI, Bisaga GN, Klimenko VM, Suvorov AN. Enterococcus faecium strain L-3 and glatiramer acetate ameliorate experimental allergic encephalomyelitis in rats by affecting different populations of immune cells. Benef Microbes. 2016 Nov 30;7(5):719-729. doi: 10.3920/BM2016.0018. Epub 2016 Sep 16. PMID: 27633171
  22. Baryshnikova NV, Ilina AS, Ermolenko EI, Uspenskiy YP, Suvorov AN. Probiotics and autoprobiotics for treatment of Helicobacter pylori infection. World J Clin Cases. 2023 Jul 16;11(20):4740-4751. doi: 10.12998/wjcc.v11.i20.4740. PMID: 37583996; PMCID: PMC10424037
  23. Suvorov A, Karaseva A, Kotyleva M, Kondratenko Y, Lavrenova N, Korobeynikov A, Kozyrev P, Kramskaya T, Leontieva G, Kudryavtsev I, Guo D, Lapidus A, Ermolenko E. Autoprobiotics as an Approach for Restoration of Personalised Microbiota. Front Microbiol. 2018 Sep 12;9:1869. doi: 10.3389/fmicb.2018.01869. PMID: 30258408; PMCID: PMC6144954
  24. Ermolenko E, Sitkin S, Vakhitov T, Solovyeva O, Karaseva A, Morozova A, Kotyleva M, Shumikhina I, Lavrenova N, Demyanova E, Dmitriev A, Suvorov A. Evaluation of the effectiveness of personalised therapy for the patients with irritable bowel syndrome. Benef Microbes. 2023 Apr 18;14(2):119-130. doi: 10.3920/BM2022.0053. Epub 2023 Mar 27. PMID: 36970947.
  25. Ermolenko E, Kotyleva M, Kotrova A, Tichonov S, Lavrenova N, Voropaeva L, Topalova Y, Karaseva A, Azarov D, Ermolenko K, Druzhininskii D, Dmitriev A, Shishkin A, Suvorov A. Consortium of Indigenous Fecal Bacteria in the Treatment of Metabolic Syndrome. Microorganisms. 2022 Aug 5;10(8):1574. doi: 10.3390/microorganisms10081574. PMID: 36013992; PMCID: PMC9414820.
  26. Ermolenko E, Baryshnikova N, Alekhina G, Zakharenko A, Ten O, Kashchenko V, Novikova N, Gushchina O, Ovchinnikov T, Morozova A, Ilina A, Karaseva A, Tsapieva A, Gladyshev N, Dmitriev A, Suvorov A. Autoprobiotics in the Treatment of Patients with Colorectal Cancer in the Early Postoperative Period. Microorganisms. 2024 May 13;12(5):980. doi: 10.3390/microorganisms12050980. PMID: 38792809; PMCID: PMC11124500
  27. Logunov DY, Dolzhikova IV, Shcheblyakov DV, Tukhvatulin AI, Zubkova OV, Dzharullaeva AS, Kovyrshina AV, Lubenets NL, Grousova DM, Erokhova AS, Botikov AG, Izhaeva FM, Popova O, Ozharovskaya TA, Esmagambetov IB, Favorskaya IA, Zrelkin DI, Voronina DV, Shcherbinin DN, Semikhin AS, Simakova YV, Tokarskaya EA, Egorova DA, Shmarov MM, Nikitenko NA, Gushchin VA, Smolyarchuk EA, Zyryanov SK, Borisevich SV, Naroditsky BS, Gintsburg AL; Gam-COVID-Vac Vaccine Trial Group. Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia. Lancet. 2021 Feb 20;397(10275):671-681. doi: 10.1016/S0140-6736(21)00234-8. Epub 2021 Feb 2. Erratum in: Lancet. 2021 Feb 20;397(10275):670. doi: 10.1016/S0140-6736(21)00386-X. PMID: 33545094; PMCID: PMC7852454. Logunov DY, Dolzhikova IV, Shcheblyakov DV, Tukhvatulin AI, Zubkova OV, Dzharullaeva AS, Kovyrshina AV, Lubenets NL, Grousova DM, Erokhova AS, Botikov AG, Izhaeva FM, Popova O, Ozharovskaya TA, Esmagambetov IB, Favorskaya IA, Zrelkin DI, Voronina DV, Shcherbinin DN, Semikhin AS, Simakova YV, Tokarskaya EA, Egorova DA, Shmarov MM, Nikitenko NA, Gushchin VA, Smolyarchuk EA, Zyryanov SK, Borisevich SV, Naroditsky BS, Gintsburg AL; Gam-COVID-Vac Vaccine Trial Group. Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia. Lancet. 2021 Feb 20;397(10275):671-681. doi: 10.1016/S0140-6736(21)00234-8. Epub 2021 Feb 2. Erratum in: Lancet. 2021 Feb 20;397(10275):670. doi: 10.1016/S0140-6736(21)00386-X. PMID: 33545094; PMCID: PMC7852454.
  28. Suvorov A, Loginova S, Leontieva G, Gupalova T, Desheva Y, Korzhevskii D, Kramskaya T, Bormotova E, Koroleva I, Kopteva O, Kirik O, Shchukina V, Savenko S, Kutaev D, Borisevitch S. SARS-CoV-2 Spike Protein-Expressing Enterococcus for Oral Vaccination: Immunogenicity and Protection. Vaccines (Basel). 2023 Nov 14;11(11):1714. doi: 10.3390/vaccines11111714. PMID: 38006046; PMCID: PMC10675790

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) Eco-Vector


СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС 77 - 74760 от 29.12.2018 г.